The new healthcare reform law includes a powerful new incentive for biotech companies: the Therapeutic Discovery Project Credit program. This program is unique in that:

  1. Only businesses with 250 or fewer employees may qualify and
  2. Companies without tax liability can exchange their credits to Treasury for a cash grant
    Importantly, the new law also provides for an accelerated implementation timeline, with program creation slated for late Spring, 2010. The new 2-year program is limited to a total of $1 Billion, so time is short to determine how a company may benefit.

Read more in a Forbes article http://www.forbes.com/2010/03/26/health-reform-biotech-tax-credit-personal-finance-dean-zerbe.html or the attached download.

I<
Authored Date: 
04/2010